Quarterly report pursuant to Section 13 or 15(d)

Summary of Significant Accounting Policies (Details Textual)

v2.4.0.6
Summary of Significant Accounting Policies (Details Textual) (USD $)
1 Months Ended 3 Months Ended 6 Months Ended 12 Months Ended 83 Months Ended
Feb. 28, 2011
Nov. 30, 2010
Jun. 30, 2012
Jun. 30, 2011
Jun. 30, 2012
Jun. 30, 2011
Dec. 31, 2010
Jun. 30, 2012
Oct. 29, 2010
Research and Development Expense     $ 217,263 $ 224,208 $ 490,815 $ 485,654   $ 4,048,464  
Deferred Setup and Organization Costs, Amortization Period (in months)         180        
Operating Loss Carryforwards, Expiration Dates (in years)         20        
Qualified Investments, Certified, Value                 488,958
Grants Receivable                 244,479
Proceeds From Grant Receivable 116,485 127,994              
Research and Development, Government Grants To Offset Costs Incurred             244,479    
Patents [Member]
                 
Research and Development Expense     $ 88,810 $ 95,126 $ 126,972 $ 234,271   $ 1,299,585